{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:09:07Z","timestamp":1792382947328,"version":"4.4.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015502","name":"Dialysis Clinics, Inc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK138021"],"award-info":[{"award-number":["R01DK138021"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIHAR072581"],"award-info":[{"award-number":["NIHAR072581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1TR00402"],"award-info":[{"award-number":["UM1TR00402"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK134101"],"award-info":[{"award-number":["DK134101"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG03955"],"award-info":[{"award-number":["P01AG03955"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Renal osteodystrophy (ROD) leads to increased fractures, potentially due to underlying low bone turnover in chronic kidney disease (CKD). We hypothesized that indoxyl sulfate (IS), a circulating toxin elevated in CKD and a ligand for the aryl hydrocarbon receptor (AhR), may target the osteocytes leading to bone cell uncoupling in ROD. The IDG-SW3 osteocytes were cultured for 14\u00a0days (early) and 35\u00a0days (mature osteocytes) and incubated with 500\u00a0\u03bcM of IS after dose finding studies to confirm AhR activation. Long-term incubation of IS for 14\u00a0days led to decreased expression of Tnfsf11\/Tnfrsf11b ratio (RANKL\/OPG), which would increase osteoclast activity, and increased expression of Wnt inhibitors Sost and Dkk1, which would decrease bone formation in addition to decreased mineralization and alkaline phosphatase (ALP) activity. When osteocytes were incubated with IS and the AhR translocation inhibitor CH223191, mineralization and ALP activity were restored. However, the Tnfsf11\/Tnfrsf11b ratio and Sost, Dkk1 expression were not altered compared with IS alone, suggesting more complex signaling. In both early and mature osteocytes, co-culture with parathyroid hormone (PTH) and IS reversed the IS-induced upregulation of Sost and Dkk1, and IS enhanced the PTH-induced increase of the Tnfsf11\/Tnfrsf11b ratio. Co-culture of IS with PTH additively enhanced the AhR activity assessed by Cyp1a1 and Cyp1b1 expression. In summary, IS in the absence of PTH increased osteocyte messenger RNA (mRNA) Wnt inhibitor expression in both early and mature osteocytes, decreased mRNA expression ofTnfsf11\/Tnfrsf11b ratio and decreased mineralization in early osteocytes. These changes would lead to decreased resorption and formation resulting in low bone remodeling. These data suggest IS may be important in the underlying low turnover bone disease observed in CKD when PTH is not elevated. In addition, when PTH is elevated, IS interacts to further increase Tnfsf11\/Tnfrsf11b ratio for osteoclast activity in both early and mature osteocytes, which would worsen bone resorption.<\/jats:p>","DOI":"10.1093\/jbmrpl\/ziae136","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:47:53Z","timestamp":1730209673000},"source":"Crossref","is-referenced-by-count":11,"title":["The uremic toxin indoxyl sulfate decreases osteocyte RANKL\/OPG and increases Wnt inhibitor RNA expression that is reversed by PTH"],"prefix":"10.1093","volume":"9","author":[{"given":"Neal X","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalisha D","family":"O\u2019Neill","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E","family":"Wilson","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruthi","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Bonewald","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Orthopaedic Surgery, Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3562-9725","authenticated-orcid":false,"given":"Sharon M","family":"Moe","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology and Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]},{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine , Indianapolis, IN 46202,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"2024121101222639900_ref1","volume-title":"Chronic Kidney Disease Initiative","author":"Prevention CDC","year":"2022"},{"issue":"11","key":"2024121101222639900_ref2","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2024121101222639900_ref3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: a new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"2024121101222639900_ref4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/ckj\/sfy061","article-title":"Novel insights into parathyroid hormone: report of the parathyroid day in chronic kidney disease","volume":"12","author":"Urena-Torres","year":"2019","journal-title":"Clin Kidney J"},{"issue":"8","key":"2024121101222639900_ref5","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.2215\/CJN.10901012","article-title":"Temporal trends in the incidence, treatment, and outcomes of hip fracture in older patients initiating dialysis in the United States","volume":"8","author":"Nair","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"2024121101222639900_ref6","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1093\/ckj\/sfab081","article-title":"Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease stages 3 and 4","volume":"14","author":"Neto","year":"2021","journal-title":"Clin Kidney J"},{"issue":"2","key":"2024121101222639900_ref7","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s00223-018-0491-4","article-title":"Association of serum sclerostin with bone sclerostin in chronic kidney disease is lost in glucocorticoid treated patients","volume":"104","author":"Boltenstal","year":"2019","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"2024121101222639900_ref8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteocytes, and chronic kidney disease\u2014mineral bone disorder","volume":"28","author":"Moyses","year":"2015","journal-title":"Semin Dial"},{"issue":"7","key":"2024121101222639900_ref9","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2024121101222639900_ref10","doi-asserted-by":"publisher","first-page":"e0132589","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2024121101222639900_ref11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.7150\/ijms.48492","article-title":"P-cresol and indoxyl sulfate impair osteogenic differentiation by triggering mesenchymal stem cell senescence","volume":"18","author":"Kamprom","year":"2021","journal-title":"Int J Med Sci"},{"issue":"8","key":"2024121101222639900_ref12","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int"},{"key":"2024121101222639900_ref13","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.bcp.2017.08.016","article-title":"Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP\/PI3K\/PKC\/PKA\/NF-kappaB signaling pathway in secondary hyperparathyroidism","volume":"145","author":"Watanabe","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2024121101222639900_ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000476074","article-title":"Aryl hydrocarbon receptor activation in chronic kidney disease: role of uremic toxins","volume":"137","author":"Brito","year":"2017","journal-title":"Nephron"},{"issue":"18","key":"2024121101222639900_ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186654","article-title":"Aryl hydrocarbon receptor (AHR) ligands as selective AHR modulators (SAhRMs)","volume":"21","author":"Safe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2024121101222639900_ref16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pbiomolbio.2017.12.005","article-title":"The role of aryl hydrocarbon receptor in bone remodeling","volume":"134","author":"Yu","year":"2018","journal-title":"Prog Biophys Mol Biol"},{"issue":"1","key":"2024121101222639900_ref17","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.taap.2013.09.002","article-title":"New insights to the role of aryl hydrocarbon receptor in bone phenotype and in dioxin-induced modulation of bone microarchitecture and material properties","volume":"273","author":"Herlin","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2024121101222639900_ref18","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11010007","article-title":"Effects of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and dioxin-like PCBs on teeth and bones in animals and humans","volume":"11","author":"Takiguchi","year":"2022","journal-title":"Toxins"},{"issue":"1","key":"2024121101222639900_ref19","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev-physiol-021119-034332","article-title":"The osteocyte: new insights","volume":"82","author":"Robling","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"2024121101222639900_ref20","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"issue":"5","key":"2024121101222639900_ref21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/jbmr.1567","article-title":"Demonstration of osteocytic perilacunar\/canalicular remodeling in mice during lactation","volume":"27","author":"Qing","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024121101222639900_ref22","first-page":"292","article-title":"Physiological and pathological osteocytic osteolysis","volume":"18","author":"Tsourdi","year":"2018","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"2024121101222639900_ref23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bone.2018.05.002","article-title":"Osteocytic perilacunar\/canalicular turnover in hemodialysis patients with high and low serum PTH levels","volume":"113","author":"Yajima","year":"2018","journal-title":"Bone"},{"issue":"7","key":"2024121101222639900_ref24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/jbmr.4574","article-title":"Calcimimetics Alter periosteal and perilacunar bone matrix composition and material properties in early chronic kidney disease","volume":"37","author":"Damrath","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024121101222639900_ref25","first-page":"196","article-title":"Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD)","volume":"19","author":"Misof","year":"2019","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"5","key":"2024121101222639900_ref26","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.kint.2018.08.011","article-title":"Impaired osteocyte maturation in the pathogenesis of renal osteodystrophy","volume":"94","author":"Pereira","year":"2018","journal-title":"Kidney Int"},{"issue":"11","key":"2024121101222639900_ref27","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1002\/jbmr.465","article-title":"Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo","volume":"26","author":"Woo","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2024121101222639900_ref28","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123498","article-title":"Inhibition of human osteoclast differentiation by kynurenine through the aryl-hydrocarbon receptor pathway","volume":"10","author":"Kim","year":"2021","journal-title":"Cells"},{"issue":"6","key":"2024121101222639900_ref29","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1124\/mol.105.021832","article-title":"Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor","volume":"69","author":"Kim","year":"2006","journal-title":"Mol Pharmacol"},{"issue":"4","key":"2024121101222639900_ref30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"2024121101222639900_ref31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.kint.2017.07.019","article-title":"Matrix vesicles induce calcification of recipient vascular smooth muscle cells through multiple signaling pathways","volume":"93","author":"Chen","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"2024121101222639900_ref32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/ki.2011.139","article-title":"Calcimimetics inhibit renal pathology in rodent nephronophthisis. Kidney Int. research support, non-U.S","volume":"80","author":"Chen","year":"2011","journal-title":"Gov't Sep"},{"issue":"5","key":"2024121101222639900_ref33","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1046\/j.1523-1755.2002.00625.x","article-title":"Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells","volume":"62","author":"Chen","year":"2002","journal-title":"Kidney Int"},{"issue":"2","key":"2024121101222639900_ref34","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1021\/bi901786x","article-title":"The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor","volume":"49","author":"Schroeder","year":"2010","journal-title":"Biochemistry"},{"issue":"10","key":"2024121101222639900_ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102221","article-title":"Intermittent administration of parathyroid hormone 1-34 enhances osteogenesis of human mesenchymal stem cells by regulating protein kinase C delta","volume":"18","author":"Kuo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2024121101222639900_ref36","doi-asserted-by":"publisher","first-page":"833221","DOI":"10.3389\/fendo.2021.833221","article-title":"PTH1R actions on bone using the cAMP\/protein kinase a pathway","volume":"12","author":"Martin","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2024121101222639900_ref37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"2024121101222639900_ref38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/jbmr.2372","article-title":"Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy","volume":"30","author":"Moe","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"8","key":"2024121101222639900_ref39","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/2211-5463.12258","article-title":"Indoxyl sulfate, a uremic toxin in chronic kidney disease, suppresses both bone formation and bone resorption","volume":"7","author":"Watanabe","year":"2017","journal-title":"FEBS Open Bio"},{"issue":"12","key":"2024121101222639900_ref40","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1359\/jbmr.1997.12.12.2014","article-title":"Establishment of an osteocyte-like cell line, MLO-Y4","volume":"12","author":"Kato","year":"1997","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024121101222639900_ref41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res"},{"key":"2024121101222639900_ref42","doi-asserted-by":"publisher","first-page":"115371","DOI":"10.1016\/j.bcp.2022.115371","article-title":"Functions of the aryl hydrocarbon receptor (AHR) beyond the canonical AHR\/ARNT signaling pathway","volume":"208","author":"Sondermann","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2024121101222639900_ref43","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.kint.2017.11.010","article-title":"Aryl hydrocarbon receptor is activated in patients and mice with chronic kidney disease","volume":"93","author":"Dou","year":"2018","journal-title":"Kidney Int"},{"issue":"10","key":"2024121101222639900_ref44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103486","article-title":"Concentration and duration of indoxyl sulfate exposure affects osteoclastogenesis by regulating NFATc1 via aryl hydrocarbon receptor","volume":"21","author":"Liu","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2024121101222639900_ref45","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1124\/mol.110.064899","article-title":"Role of epigenetic mechanisms in differential regulation of the dioxin-inducible human CYP1A1 and CYP1B1 genes","volume":"78","author":"Beedanagari","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"26","key":"2024121101222639900_ref46","doi-asserted-by":"publisher","first-page":"9218","DOI":"10.1073\/pnas.0503488102","article-title":"Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways","volume":"102","author":"Oesch-Bartlomowicz","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2024121101222639900_ref47","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1093\/ndt\/gfp007","article-title":"Oral charcoal adsorbent (AST-120) prevents progression of cardiac damage in chronic kidney disease through suppression of oxidative stress","volume":"24","author":"Fujii","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"2024121101222639900_ref48","doi-asserted-by":"publisher","first-page":"e10837","DOI":"10.1002\/jbm4.10837","article-title":"The dietary fiber inulin slows progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in a rat model of CKD","volume":"7","author":"Biruete","year":"2023","journal-title":"JBMR Plus"}],"container-title":["JBMR Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmrplus\/advance-article-pdf\/doi\/10.1093\/jbmrpl\/ziae136\/60192185\/ziae136.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/1\/ziae136\/61006725\/ziae136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article-pdf\/9\/1\/ziae136\/61006725\/ziae136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:56:49Z","timestamp":1733882209000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmrplus\/article\/doi\/10.1093\/jbmrpl\/ziae136\/7848654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmrpl\/ziae136","relation":{},"ISSN":["2473-4039"],"issn-type":[{"value":"2473-4039","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,10,29]]},"article-number":"ziae136"}}